Dongwha Pharm acquires Trung Son Pharma 51% stake for $30 mln
South Korea’s Dongwha Pharm said Thursday it will acquire a 51% stake in Vietnam’s Trung Son Pharma for KRW39.12 billion ($29.86 million).
Industries - Mon, Dec 22, 2021 | 11:30 am GMT+7
- Editor’s Picks
-
LG’s chemicals arm records modest 2023 profits in Vietnam
-
Firms with 500,000 kWh per month minimum consumption to become DPPA buyer: draft rule
-
SCG aims to fire up $5.4 bln Long Son Petrochemicals Complex in August
-
Thailand Kasikornbank’s Vietnam branch sees 2023 loss widen to $7.4 mln
-
AG&P LNG to start operating southern Vietnam LNG terminal in Sept
- Most Read
1
2
Vietnam welcomes Chinese high-tech investments: PM
Industries - Update 4 day ago
3
Vietnam Politburo has four new members
Politics - Update 2 day ago
5
- Editor’s Picks
-
LG’s chemicals arm records modest 2023 profits in Vietnam
-
Firms with 500,000 kWh per month minimum consumption to become DPPA buyer: draft rule
-
SCG aims to fire up $5.4 bln Long Son Petrochemicals Complex in August
-
Thailand Kasikornbank’s Vietnam branch sees 2023 loss widen to $7.4 mln
-
AG&P LNG to start operating southern Vietnam LNG terminal in Sept
Not found block 'box_opinion'
